Antimicrobial Drug Resistance

1. Fungal Drug Resistance – Clinical

   1. Drug Resistance in Cryptococcus neoformans

      • Kimberly E. Hanson, Barbara D. Alexander, John Perfect

      Pages 967-985

   2. Antifungal Drug Resistance in Histoplasmosis

      • L. Joseph Wheat, Patricia Connolly, Melinda Smedema, P. David Rogers

      Pages 987-992

   3. Drug Resistance in Pneumocystis jirovecii

      • Jannik Helweg-Larsen, Thomas Benfield, Joseph Kovacs, Henry Masur

      Pages 993-1007

2. Viral Drug Resistance – Clinical

   1. Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

      • Frederick G. Hayden

      Pages 1011-1033

   2. Herpesvirus Resistance

      • G. Boivin, W.L. Drew

      Pages 1035-1047

   3. Clinical Implications of HIV-1 Drug Resistance

      • Douglas L. Mayers

      Pages 1049-1060

   4. Clinical Implications of Resistance for Patients with Chronic Hepatitis B

      • Nathaniel A. Brown

      Pages 1061-1073

3. Parasitic Drug Resistance – Clinical

   1. Antimalarial Drug Resistance: Clinical Perspectives

      • Philip J. Rosenthal

      Pages 1077-1090

   2. Diagnosis and Treatment of Metronidazole-Resistant Trichomonas vaginalis Infection

      • Sarah L. Cudmore, Gary E. Garber

      Pages 1091-1100

   3. Drug Resistance in Leishmania: Clinical Perspectives

      • Shyam Sundar, Madhukar Rai

      Pages 1101-1112

   4. Human African Trypanosomiasis

      • Jacques Pépin, Honoré Méda

      Pages 1113-1119

   5. Drug Resistance in Toxoplasma gondii

      • Paul F. G. Sims

      Pages 1121-1126

   6. Drug Resistance in the Sheep Nematode Parasite Haemonchus contortus, Mechanisms and Clinical Perspectives

      • Marleen H. Roos

      Pages 1127-1132

4. Measurements of Drug Resistance

   1. In Vitro Performance and Analysis of Combination Anti-infective Evaluations

      • Robert W. Buckheit, R. Dwayne Lunsford

      Pages 1135-1149

   2. Antimicrobial Susceptibility Testing Methods for Bacterial Pathogens

      • Fred C. Tenover

      Pages 1151-1159

   3. Drug Resistance Assays for Mycobacterium tuberculosis

      • Leonid Heifets, Gerard Cangelosi

      Pages 1161-1170

   4. Fungal Drug Resistance Assays

      • Sevtap Arikan, John H. Rex

      Pages 1171-1186

   5. Viral Phenotypic Resistance Assays

      • Neil Parkin

      Pages 1187-1199

   6. Drug Resistance Assays for Parasites

      • N. C. Sangster, G. N. Maitland, S. Geerts, Saskia Decuypere, Jean-Claude Dujardin, J. A. Upcroft et al.

      Pages 1201-1225

   7. Genotypic Drug Resistance Assays

      • A. Huletsky, M. G. Bergeron

      Pages 1227-1248

This ? rst edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to have a comprehensive resource of information on antimicrobial drug resistance that encompassed the current information available for bacteria, fungi, protozoa and viruses. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students and fellows in training. We have endeavored to provide this information in a style which would be accessible to the broad community of persons who are concerned with the impact of drug resistance in our cl- ics and across the broader global communities. Antimicrobial Drug Resistance is divided into Volume 1 which has sections covering a general overview of drug resistance and mechanisms of drug resistance ? rst for classes of drugs and then by individual microbial agents including bacteria, fungi, protozoa and viruses. Volume 2 addresses clinical, epidemiologic and public health aspects of drug resistance along with an overview of the conduct and interpretation of speci? c drug resistance assays. Together, these two volumes offer a comprehensive source of information on drug resistance issues by the experts in each topic.

• Antimicrobial
• Aspects
• Clinical
• Handbook
• Hepatitis
• International Public Health
• Malaria
• Mayers
• Resistance
• bacterial pathogens
• epidemiological
• infection
• infections
• infectious
• public health issues
• infectious diseases

From the reviews:

“This book is a comprehensive guide to the state of the field as far as clinical practice is concerned. … There is good coverage of the wider spectrum of pathogens: viruses, fungi and parasites are addressed as well as bacterial infections. Each contribution is exhaustive and will appeal very much to the clinical microbiologist and infectious disease specialist. … This is certainly a reference book, and every diagnostic laboratory would derive value in having a copy on its shelves.” (Colin Howard, Microbiology Today, June, 2010)

• Executive Vice President & Chief Medical Officer, Idenix Pharmaceuticals, Cambridge, USA

  Douglas L. Mayers

Policies and ethics